Simultaneous Occurrence of HER2 Mutations in EGFR Mutant NSCLC: Case Reports

Simultaneous Occurrence of HER2 Mutations in EGFR Mutant NSCLC: Case Reports

HER2 mutation and amplification have been identified as distinct molecular targets in lung cancer with different therapeutic and prognostic values. The coexistence of HER2 and EGFR mutations is extremely rare, and therefore, no data exist on the best treatment in these cases.

Saved in:
Bibliographic Details
Main Authors: Blerina Resuli, MD, Diego Kauffmann-Guerrero, MD, Jürgen Behr, MD, Amanda Tufman, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:JTO Clinical and Research Reports
Subjects:
Afatinib
Case report
EGFR mutation
HER2 mutations
Non–small cell lung cancer
Osimertinib
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364324000894
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items